John Wilson

John Wilson is a prominent figure in the cell and gene therapy manufacturing industry. Here are the key details about him:

Professional Background

John Wilson is the Founder, CEO, and VP of Quality at CellReady, a company he established in May 2023.1 CellReady is designed to accelerate the development of cell and gene therapy (CGT) companies by providing essential resources and expertise.1

Other Roles and Ventures

• Wilson Wolf Manufacturing Corporation: Founder and CEO since 1995
• ScaleReady: Co-Founder and Board Member since January 20201
• Wilson Foundation Minnesota: Founder and Board Member since 20221

Expertise and Contributions

John Wilson has made significant contributions to the field of cell and gene therapy manufacturing:

• He is known for inventing and developing the G-Rex® technology, widely recognized as a leading platform for cell and gene therapy scale-up and scale-out.
• Through Wilson Wolf, he has been instrumental in creating devices for various CGT applications, including CAR, CTL, NK, Treg, TIL, and Neo-Antigen therapies.
• His work aims to simplify and improve the manufacturing processes for cell and gene therapies, making them more practical and cost-effective.23

Educational Background

John Wilson holds the following degrees:

• Mechanical Engineering BS from the University of Minnesota
• Business Administration BA from Hamline University
• Economics BA from Hamline University2

Industry Impact

Wilson's companies and initiatives have had a significant impact on the CGT industry:

• ScaleReady, a joint venture he co-founded, focuses on revolutionizing CGT manufacturing.1
• CellReady aims to cut development time and costs for CGT companies, potentially saving them years and millions of dollars in the process.1
• He has been involved in launching grant programs to support CGT development and manufacturing, such as the $20 Million G-Rex® Grant Program announced in 2024.4

John Wilson's LinkedIn username is john-wilson-b778884, as mentioned in the query.